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Introduction
One cannot but point out that the variety of topics related to 
zoonoses, and in particular zoonoses transmitted by ticks, 
is fascinating and ranges from environmental to clinical 
sciences, also in emergency situations, from veterinary sci-
ences to human epidemiology, in a finely woven network 
of interactive ecological, social and health factors. An-
thropic and cultural factors are correlated to the presence 
and distribution of zoonoses and, in most cases, become 
risk factors themselves. The epidemiology of zoonoses 
is, in fact, closely tied to the socio-economic conditions 
and the characteristics of the different rural areas, where 
complex interrelations and close living conditions exist 
between men and animals and are often unavoidable. 
In recent years the situation has become even worse, 
making zoonoses one of the most serious problems of 
Public Health. The list of zoonoses is extensive and the 
agents responsible for infection include bacteria, fungi, 
chlamydiae, rickettsiae, viruses and protozoa, transmit-
ted by faeces, food, animal bites or inoculations by ar-
thropods. The role of arthropods is significant and is in 
constant expansion. Human activities modify the ecologi-
cal balance and facilitate an increase in arthropods and, 
consequently, the spread of pathogens they transmit with 
their relative pathologies [1-3]. Because of the vast range 
of hosts among pets and wild animals, it is very difficult 
to control arthropods and their respective pathologies. 
The same tick may have different specificities of hosts, 
the same host may be parasitized by various species of 
ticks. Mammals, birds, and reptiles can be hosts for ticks, 
which transmit more pathogens than any other vector and 
can guarantee the transmission and continuance in nature 
even by transtadial or transovarial means. In recent years, 
moreover, the epidemiology of arthropods has changed: 
new forms of transmission have been described and new 
pathogens have been isolated [4-8].
Bioecology of ehrlichiae
Ehrlichiae are obligate, gram-negative, intracellular bac-
teria. Inside the cells the initial bodies and the morulae 
can be identified and can be stained with Romanowsky 
method (acidophilic staining), Gimenez method (az-
urophilic granules) or with acridine orange [9]. They 
are present in the blood in the acute phase and can be 
isolated from it. The developmental cycle takes place 
between mammals and arthropod vectors, ticks, which 
have also demonstrated transtadial transmission. Eco-
logical and anthropic factors determine the distribution 
of arthropod vectors and their consequent, correlated 
pathologies. Geographic factors, the physical environ-
ment, the composition of the ground cover, the biodi-
versity of the flora, the hydrology and humidity of the 
ground, the distribution and density of the fauna that 
acts as a reservoir and other ecological variables can act 
as predictors to build probability models of the distribu-
tion of vectors and their pathogen hosts [10]. The role 
of wildlife in supporting the diffusion of zoonoses was 
recently described [11, 12]. The detection of the pres-
ence of antibody reactivity in human and animal serums 
is used to monitor the circulation of the pathogens and 
their vectors. In the USA the growth of the white-tailed 
deer, Odocoileus virginianus during the last century 
has been connected to the simultaneous increase of the 
population of Amblyomma and its pathogen hosts. The 
white-tailed deer is an essential host in the evolutive 
stages of Amblyomma, and acts as a reservoir for Ehr-
lichia chaffeensis (E. chaffeensis), Ehrlichia ewingii 
(E. ewingii), Borrelia lonestari and others [13-15]. The 
racoon (Procyonis lotor) is also present in the epidemi-
ology of Ehrlichia [16]. Rhipicephalus sanguineus (R. 
sanguineus) is mainly responsible for the transmission 
of the agent Ehrlichia canis (E. canis), while Amblyo-
mma americanum (A. americanum – lonestar tick) is 
responsible for the transmission of Human Monocytic 
Ehrlichiosis (HME) and of Human Ehrlichiosis Ewingii 
(HEE) agents. The transmission of Human Granulocy-
totropic Anaplasmosis (HGA) has as a vector the tick 
Ixodes scapularis (I. scapularis – black-legged tick) in 
the eastern USA, Ixodes pacificus (I. pacificus) along 
the US west coast and, prevalently, Ixodes ricinus (I. 
ricinus) in Europe. Other Ixodidae have also been in-
cluded in the list of possible or suspected vectors of 
Ehrlichia and Anaplasma. Anaplasma phagocytophilum 
(A. phagocytophilum) was identified in Ixodes exagonus 
(5,9%) in the Netherlands (17), in Ixodes persulcatus 
(4%) in northeastern China [18], in Inner Mongolia 
and in the Heilongjiang Province [19], in Korea (1%) 
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with E. chaffeensis as well [20], in Japan (1%) [21], 
in eastern Europe (2,4%) [22]. This agent was also as-
sociated with Ixodes spinipalpis in the USA [23,24], 
Ixodes trianguliceps in the United Kingdom [25] and 
reported in Ixodes ventalloi in Portugal [26] and in Ixo-
des dammini removed from a patient with HGA [27]. A. 
phagocytophilum was detected in Dermacentor silvar-
um [18], in Dermacentor reticulatus (D. reticulatus) in 
Austria [28], in Dermacentor variabilis (D. variabilis) 
in California [29]. D. reticulatus was found to occur at 
far more sites than previously known in Germany [30] 
and was reported to be the major tick species attacking 
dogs in the Warsaw area [31]. The competency of D. 
reticulatus as a vector of Anaplasma, however, has yet 
to be demonstrated. Wild rodents were thought to be 
implicated in tick-rodent cycles and the prevalence of 
A. phagocytophilum in alternate ticks beside the known 
vector species was supposed to be attributable to a sec-
ondary maintenance cycle in relatively host specific, 
usually nonhuman-biting ticks and their hosts [32].
Canine ehrlichiosis (E. canis, E. ewingii)
E. canis and E. ewingii, belonging to the family Anaplas-
mataceae, genus Ehrlichia, are the agents respectively 
of Canine Ehrlichiosis (CE) and Canine Granulocytic 
Ehrlichiosis (CGE). E. canis circulates widely in dogs. 
Its vector is R. sanguineus. Symptoms of the illness 
observed clinically in dogs include fever, asthenia and 
anorexia, nasal discharge, red rheumy eyes, splenom-
egaly, lymphadenopathy, dyspnea. There is also damage 
to the liver, signs of haemorrhage, epistaxis, haematuria 
and melena, thrombocytopenia with hypogranulocyto-
sis [33]. The infection was documented in the Mediter-
ranean area, Israel, Egypt, Tunisia, Portugal, Spain, 
Greece [34-39], but also in Germany, Switzerland, UK, 
Sweden, Poland, The Netherlands [40-45] and in dif-
ferent parts of Africa, India, South-East Asia [46, 47]. 
In Italy, initially in Sicily and later in Sardinia and then 
in all of Italy: from 50 to 72% of the dogs examined 
tested positive; the mortality oscillated between 6 and 
12% [48-50]. Army dogs in Senegal had a 49 to 85% 
positivity, 50% in Chad and 46% in Zimbabwe. Clinical 
and serological data from Israel and Morocco showed an 
elevated prevalence and an elevated mortality [51-53]. 
In Oklahoma from 3 to 6% of the dogs examined tested 
positive to PCR for E. canis, E. ewingii, E. chaffeensis. 
PCR positivity was also observed in various species of 
ticks (R. sanguineus, D. variabilis, Anaplasma ameri-
canum) [54]. In Sicily, antibody reactivity to E. canis 
was found in 55% of stray dogs and in 11% of pet dogs: 
these data evidenced an intense circulation of the agent 
in unprotected environments. On the contrary, human 
serums, taken from feverish patients and healthy blood 
donors, tested negative for E. canis and E. chaffeensis, 
despite the proved presence and the high density of the 
arthropod vector, Rhipicephalus [55]. Recent studies 
carried out in Brazil on haemorrhagic and thrombocy-
topenic dogs revealed an elevated incidence of E. canis 
infections, but also the presence of Babesia and Ana-
plasma platys [56], and in the south-east (Saõ Paolo) a 
study on a group of dogs showed an 80% positivity to 
PCR for E. canis [57]. An intense circulation of E. canis 
was found in Thailand and in Cameroon, revealing a 
considerable circulation of strains of E. canis but also 
of E. ewingii, identical in the genetic sequence to North 
American strains [58-60]. Studies conducted in Israel 
suggested that some symptoms observed in E. canis 
infections can be attributed to immune complexes and 
to the presence of antiplatelet antibodies [61]. A form of 
recurrent pyodermitis from positive coagulase Staphylo-
coccus intermedius, linked to chronic Ehrlichiosis, has 
been described, especially in German shepherd [62].
Human ehrlichioses 
Between the 1980s and early 2000s, new agents of the 
Order Rickettsiales were identified in the world. Some 
tick-borne species were isolated before their patho-
genic role in men was recognized. Rickettsia parkeri, 
among others, was classified as a pathogen for men 
sixty years after it had been isolated in ticks. Rickettsia 
felis, a new Rickettsia in the Spotted Fever group, was 
associated with fleas as vectors and only recently was 
its pathogenicity for men identified [7, 8, 63]. Rickett-
sia ambliommi was identified as a possible cause of a 
rickettsiosis previously reported as Rocky Mountain 
Spotted Fever [64].
Ehrlichia and Anaplasma, gram-negative, intracellular, 
wide-spread micro-organisms, already classified in the 
Rickettsiaceae and considered to be of prevalent veteri-
narian interest were recently associated with numerous 
clinical evidences in men, revealing a diffusion in the 
human sphere which is much greater than previously 
believed [65].
Human ehrlichiosis and anaplasmosis, refer to infec-
tions with at least three different bacteria, obligate 
intracellular parasites, belonging to 2 genera of the 
family Anaplasmataceae: E. chaffeensis, E. Ewingii, 
two species of the genus Ehrlichia, and A. phagocy-
tophilum, of the genus Anaplasma. A new species with 
strong tropism for mononuclear WBC was isolated in 
1991 by a recruit with febrile syndrome at Fort Chaffee 
in Arkansas. The illness, called HME, was attributed to 
a new Ehrlichia: E. chaffeensis [66]. In 1994 another 
species identified in the morulae of granulocytes was 
isolated from patients in Minnesota and Wisconsin (in 
some cases resulting in death), believed to be similar to 
Ehrlichia equi (E. equi) or Ehrlichia phagocytophila (E. 
phagocytophila) and called Human Granulocytotropic 
Ehrlichiosis agent, today an Anaplasmosis (HGA), 
caused by A. phagocytophilum [67]. Since then nearly 
4500 cases of HME have been reported in the south-
eastern United States and nearly 3000 cases of HGA 
in the western and northeastern USA. E. ewingii was, 
in 1999, recognized as agent of another human Ehrli-
chiosis (HEE) [68].The incidence of these infections is 
increasing constantly where the appropriate tick vectors 
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are found and is connected to the increase in arthropod 
populations. The diseases have non-specific clinical 
signs and important laboratory data (thrombocytopenia, 
leukopenia, hypertransaminasemia), common to the 
three infections. Dermatologic manifestations may help 
in sustaining a suspected diagnosis [69]. Infections are 
more prevalent and may have severe clinical picture 
and lethal outcome in immuno-compromised hosts, in 
particular in HIV infections [70]. The practical chal-
lenge is posed by the difficult diagnostic dilemma with 
the insurgence of clinical signs. The clinical suspicion 
of a tick bite and the orientation towards the possible 
infective agents becomes extremely important. Begin-
ning antibiotic treatment promptly, when it is more ef-
ficacious and can resolve the situation, can help prevent 
undesirable consequences [71]. Human cases require for 
confirmation to be defined by some essential character-
istic: fever with history of exposure to tick or tick bite; 
at least a ≥ 4 fold increase of antibody titre in acute and 
convalescent sera; positive PCR and sequencing of the 
amplicons demonstrating specific DNA or isolation of 
the agent from blood. A group of specialists and experts 
of the CDC in Atlanta, GA, have developed guidelines 
for health workers which focus on the practical aspects 
related to the diagnosis of tick-borne rickettsial diseases 
(Rickettsiales Order) and concerning the epidemiology, 
clinical approach, treatment and laboratory diagno-
sis [72]. In Europe, the ESCMID Study Group on Cox-
iella, Anaplasma, Rickettsia and Bartonella, has also 
published comprehensive guidelines for the diagnosis 
of tick-borne bacterial diseases, to help clinicians and 
microbiologists in diagnosing and have a better under-
standing of these infections [73]. 
HME, E. chaffeensis
After the initial findings at the beginning of the 1990s, 
as reported above, the number cases of HME reported 
to the CDC amounted to several thousand. In Georgia 
serological, cell culture and molecular identification tests 
demonstrated a prevalence of as high as 92% of infection 
in white-tailed deer (Odocoileus virginianus), but an el-
evated prevalence was also shown in racoons (Procyonis 
lotor) and in opossums (Didelphis virgilianus). A consid-
erable presence of E. chaffeensis was reported in the dom-
inant tick species A. americanum [13-16, 74]. In Europe, 
the illness was suspected based upon serological tests in 
Portugal, in Spain, in Belgium, in the UK [75-77], but 
this disease has never been proven. The most significant 
clinical data are undifferentiated fever, accompanied by 
one or more systemic manifestations: general malaise 
and cephalea (90%), myalgia, nausea and vomiting 
(70/80%), arthralgia, diarrhea and abdominal pain; rash 
is less common than in rickettsioses (20%), interstitial 
pneumonia and cough (30%), lymphoadenopathy and 
stupor (15%). Mortality is around 10%. Laboratory data 
show: leukopenia, thrombocytopenia, anemia, hyper-
transaminasemia, CRP, elevated ESR, hyperbilirubine-
mia, hypercreatininemia [78]. Some patients developed 
a systemic involvement, neurological symptoms or 
focus deficit. Cases of paralysis of the trochlear nerve 
and evidence of lymphocytic meningitis [79], and se-
vere myocarditis were reported [80]. Severe infections 
from E. chaffeensis were described in transplanted and 
immuno-deficient patients [81]. HME causes a serious 
syndrome in children, state of shock, with kidney failure 
and respiratory difficulty, cognitive deficit and neuro-
logical symptoms [82]. A pediatric case from Venezuela 
was also recently reported [83]. E. chaffeensis may 
also infect dogs. The infection was first reported in 
dogs in the USA and, recently, was identified in South 
America [84].
HGA, A. phagocytophilum
The first patient to have recognized HGA was hos-
pitalized in Duluth, Minnesota in 1990. However the 
infection remained undefined until this new species was 
detected in 1994, in 12 patients from Minnesota and 
Wisconsin who had cytoplasmic inclusions (morulae) in 
the leukocytes, and not in the monocytes. There was an 
immune response reactive to this species and negative 
for E. chaffeensis [67]. This micro-organism was ini-
tially, related to E. phagocytophila and to E .equi [85]. 
The main vector has been identified as I. scapularis in 
the eastern quadrant of USA and I. pacificus in the west 
coast. Most cases of HGA have been contracted in geo-
graphic regions that are endemic for Lyme borreliosis as 
the host arthropods for A. phagocytophilum are also vec-
tors for Borrelia burgdorferi. Human anaplasmosis is 
an acute infection, with incubation period of 5-21 days, 
occurring prevalently between April and October. Male 
patients outnumber female patients and about 75% had a 
tick bite prior to their illness. Differently from rickettsi-
osis, there is no eschar where inoculation took place. 
Clinical and laboratory data are similar to those reported 
for HME but despite clinical similarities each disease 
may have unique features: a greater severity and higher 
case-fatality rate for HME, and, in USA, a higher preva-
lence of opportunistic infections may undergo for HGA. 
Opportunistic infections are not yet described in Europe 
where the disease appears generally milder. Older indi-
viduals and immune-compromised patients may have a 
considerably more severe course of the illness. Rashes 
have been reported only occasionally. Characteristic 
clusters of bacteria (morulae) can be observed in the 
cytoplasm of peripheral blood granulocytes. Laboratory 
parameters may show leukopenia, thrombocytopenia, 
increase in transaminases, CRP and ESR [86]. Acute 
Anaplasma infection may have a presentation similar to 
the initial phase of infection by tick-borne encephalitis 
virus, endemic in Central and northeastern Europe [87] 
Several cases presented as atypical pneumonitis [88]. 
One case with fever and facial dyplegia was described in 
Boston [89]. E. equi isolated from cases of equine infec-
tion was found to be identical to those isolated from hu-
man infection (HGA) in northern California [90]. Sero-
conversion for A. phagocytophilum, testing acute-phase 
E. SIDOTI, G. TRINGALI
12
and convalescent-phase serum samples is a sensitive 
and specific serologic tool for clinical confirmation; in-
crease in antibody titre remains elevated, even for years. 
Treatment with doxycycline usually results in complete 
cure. In Europe, the disease was first described in Slov-
enia in 1997 [91]. It is not I. scapularis, but I. ricinus 
that, in Europe, has the greatest vector responsibility. 
In Slovenia nucleotide sequences amplified by isolated 
agents of HGA were shown to be identical to the granu-
locytic agents isolated from the I. ricinus ticks [92]. In 
Europe serological evidence of human anaplasmosis 
was reported in most European Countries: in Spain, in 
the Czech Republic, in Slovenia, in Croatia, in France, 
Greece, Austria, Poland, Sweden, Denmark, Norway, 
Finland, The Netherlands [93-105]. Much less cases re-
ported from Slovenia, Spain, Austria, Italy, The Nether-
lands, Sweden, Poland and France, have been confirmed 
by presence of morulae in circulating granulocytes, PCR 
based detection of the organism in the blood and a four 
fold increase in specific antibody [106-113].
The first case in children, in Slovenia, was de-
scribed [114]. A case of infection with meningeal 
consequences, encephalopatia and seizures, was also 
reported [115]. Interestingly, a case of infection, fulfill-
ing the criteria for confirmed HGA, in a sero-negative 
patient was observed in Sicily [116]. Serologic testing 
and genetic identification were also carried out in Sic-
ily on a significant number of animal species, horses, 
donkeys, cattle, sheep, goats, dogs and guinea pigs. 
Dogs, sheep and goats were found to be reservoirs for 
Anaplasma [117]. An Italian research reported serop-
ositivity for A. phagocytophilum in 6.3% of the human 
serum examined; 13.3% seropositivity was also found in 
sheep and 5-6% in dogs. Positivity for E. equi was found 
in horses with and without symptoms. The positivity in 
human serums, in pets and in stray dogs was confirmed 
with the identification of Anaplasma species circulating 
in I. ricinus [118, 119]. A nosocomial transmission of 
the disease was described in China [120].
HEE, E. ewingii
Several cases of HEE have been linked to E. ewingii, 
an agent previously reported as a cause of granulocytic 
ehrlichiosis in dogs [68]. E. ewingii is the only Ehrlichia 
species known to infect neutrophils. Because the organ-
ism has never been cultured, antigens are not available. 
Thus, infection may be diagnosed by DNA detected 
in clinical specimens via amplification of specific tar-
get by PCR assay. E. ewingii has the same vector and 
vertebrate hosts as HME, The lone star tick, namely A. 
americanum, is the vector of E. chaffeensis as well as E. 
ewingii. But E. ewingii seems to have a greater spectrum 
of prevalence in numerous tick species, in particular 
D. variabilis and R. sanguineus. The white-tailed deer 
(Odocoileus virgianus) was shown to be host and reser-
voir also of E. ewingii [121]. E. ewingii infection may 
be clinically indistinguishable from infection caused by 
E. chaffeensis and has symptoms and clinical courses 
similar to HGA: is an acute, febrile illness with leukope-
nia, thrombocytopenia, anemia, hepatitis, accompanied 
by headhache, myalgia, arthralgia, vomiting, anorexia. 
The rash is less frequent than in HME. Severe mani-
festations include organ (renal and respiratory) failure, 
pulmonary infiltrates, encephalopathy, meningitis. Most 
patients with this form of Ehrlichiosis had different 
pathologies causing immune-suppression: transplanta-
tion, HIV infection, splenectomy, immunosuppressive 
drugs [70, 81].
Human infection caused by E. canis
The agent of canine monocytic ehrlichiosis (CME), E. 
canis, is an obligate intracellular gram-negative bac-
terium. Many years have passed since Donatien and 
Lestoquard described the haemorrhagic illness of dogs, 
linked to the infestation of ticks and caused by an or-
ganism similar to Rickettsia [122]. It was not, however, 
a Rickettsia, as believed initially, but an Ehrlichia: E. 
canis, genus defined in 1945, a name in honor of P. 
Ehrlich.
In 1986, a serious febrile illness (intense cephalalgy, 
myalgia, thrombocytopenia hypoxia, stupor) was de-
scribed in a 51-year-old patient following a tick bite, 
complicated by kidney failure, gastrointestinal haemor-
rhage and systemic candidosis. The case was attributed 
to E. canis but later confirmed as E. chaffeensis [123]. 
The first human infection and culture isolation of E. 
canis was reported in 1996 in Lara, Venezuela, from 
a 27 years hold veterinarian, apparently chronically 
infected but asymptomatic. The strain was designated 
Venezuelan Human Ehrlichia (VHE) [124]. The iso-
lated VHE sp., by 16S rRNA base sequence comparison 
was found to be closely related to E. canis. Antigenic 
and genetic characterization brought to the conclusion 
that VHE was a new strain or a subspecies of E. canis 
causing asymptomatic persistent infection in humans.
The 16S rRNA 1,408-bp sequence of VHE isolate, 
subsequently, was demonstrated identical to that of a 
Venezuelan Dog Ehrlichia (VDE) isolated from one 
dog blood sample and was closely related (99,9%) to 
that of E. canis Oklahoma. An intense circulation of 
the agent in dogs and ticks, R. sanguineus, moreover, 
was evidenced in the region, all isolates having the 
same genetic and antigenic profiles. These observations 
suggested that dog act as reservoir of human E. canis 
infection and that R. sanguineus serves as vector [125]. 
Human infections with E. canis in symptomatic patients 
were also reported from Lara State in Venezuela. Six in 
a group of 20 patients admitted to the Central Hospital 
in Lara State, with fever, malaise, nausea, vomiting, 
diarrhoea, haematological abnormalities were E. canis 
16S rRNA gene PCR positive. Clinical signs, haemato-
logical parameters and age distribution of PCR negative 
patients were very similar. Patients were young, none 
of these patients was immuno-suppressed [126]. These 
observations, again, evidenced the intense circulation of 
E. canis and the fact that infection with this agent may 
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not be an isolated event in Venezuela. Clinical signs 
and symptoms caused by human infection with E. canis 
are similar to those presented in HME. Clinical reports 
vary from asymptomatic infection to severe illness with 
high-grade fever, headache, myalgia, nausea, vomiting, 
anorexia. Laboratory findings show thrombocytopenia, 
leukopenia, liver enzyme abnormalities. Meningitis 
and encephalitis may occur. Signs are similar in Rocky 
Mountain spotted fever, dengue fever, mononucleosis 
or influenza. Differential diagnosis in febrile episodes 
is important and may led to delay in initiating resol-
utive therapeutic intervention. From the epidemiologi-
cal point of view serological cross reaction in E. canis, 
E. ewingii and E. chaffeensis infection may brought 
about incorrect definition of geographic distribution and 
consequent risk of human infections. Large distribution 
of the brown dog tick, R. sanguineus in other regions 
of the world, such as the Mediterranean area, were an 
intense circulation of E. canis was evidenced, may led 
to the suspicion that infection can be misdiagnosed and 
stress the need for further researches to define the effec-
tive risk of infection by E. canis in humans.
Laboratory diagnosis
Comprehensive guidelines related to the diagnosis of 
tick-borne rickettsial diseases (Rickettsiales Order) and 
concerning the epidemiology, clinical approach, treat-
ment and laboratory diagnosis, as already cited, have 
been provided by experts of CDC in Atlanta, GA, in 
USA and by the ESCMID Study Group on Coxiella, 
Anaplasma, Rickettsia and Bartonella diseases in Eu-
rope [72, 73].
The emerging of new, the high prevalence or the re-
emerging of old tick-borne bacterial diseases have in-
tensified the need for diagnostic tests.
Methods in the diagnosis of vector-borne diseases were 
at the beginnings dependent upon blood smears exami-
nation, useful for the detection of Anaplasma and Eh-
lichia morulae in circulating blood cells during the acute 
phase of infection, serological detection of the antibody 
response by indirect immunofluorescence antibody test 
(IFA), ELISA or western immune-blotting. Rickettsiae 
were also identified using histological direct immun-
ofluorescence methods on tissue biopsies of the eschar 
when present [127, 128]. Two or more serum samples, 
collected during the acute phase of infection and after 
two or three weeks, during the convalescent phase, are 
needed for serology. IFA test is the reference test used 
for antibody detection [129]. Different strain are used in 
different research centres as test antigens. Intracellular 
grown or cell-free antigen prepared by purification of 
infected cell culture, coated on glass slide and fixed with 
acetone or alcohol, are used for testing. Serological con-
firmation of infection requires seroconversion or at least 
a ≥ 4 fold increase in antibody titre. Immuno-reactive 
proteins of the external membrane from E. canis were 
recently used to monitor the antibody response and to 
attempt to develop specific ELISA [130, 131].
Isolation of germs from tissue and blood, in tissue cul-
tures or in embryonic eggs, is difficult and requires labo-
ratory equipments and trained personnel. Isolation of the 
agent requires blood samples collected during the acute 
phase of the infection. Although Anaplasma was able to 
resist for many days in samples kept at room tempera-
ture, blood samples must be kept at room temperature or 
at 4°C for not more than two days and frozen at –20°C 
if is needed to maintain infectivity for longer periods. 
Blood must be collected on EDTA, as heparinised sam-
ples may compromise results of PCR based methods. 
Blood smears for the observation of morulae in WBC 
must be prepared as soon as the blood is taken, air-dried 
and kept at room temperature. Cultivation need a level 
3 biohazard laboratory. Cells, promyelocytic HL-60 
leukemia cell line, are commonly used, maintained in 
RPMI-1640, antibiotic free medium, supplemented with 
glutamine and fetal bovine serum. 25 cm2 flasks con-
taining medium with 2 x 105 cells/ml are inoculated with 
100 μl of fresh blood or 0,5 ml of the leukocyte fraction 
of the frozen blood. Using Giemsa staining, morulae can 
be observed on days 3-7 [132, 133].
The development of DNA based approaches enhanced 
sensitivity, specificity and rapidity of a possible 
diagnosis, increased knowledge in epidemiological 
information, provided support to the clinicians for a 
better understanding of distribution and differences 
in the clinical features of these diseases. Molecular 
approaches have included PCR sequencing, RFLP 
analysis of amplified genes: the 16S rRNA gene, the 
16S-23S rRNA intergenic transcribed spacer (ITS) 
region and many others. PCR assays targeting frag-
ments of the msp2 homologues or the 16S rRNA gene 
seemed to be the most sensitive. To confirm identity, 
however, sequencing of the PCR products is neces-
sary [134-136].
Order rickettsiales 
Improvements in molecular methods led to a modifica-
tion of the Rickettsiales Order, which has recently un-
dergone an important reorganization [137]. The Order, 
therefore, contains three families:
• Family Rickettsiaceae;
• Family Anaplasmataceae;
• Family Bartonellaceae.
From the Family Rickettsiaceae have been removed nu-
merous elements. The Rickettsia genus has maintained 
the two “classic” groups of Spotted Fevers and Typhus. 
For the Rickettsiae of the Scrub Typhus group, which 
are different because do not have a peptoglican and lack 
an external capsule-like layer, a new genus has been cre-
ated: Orientia (Orientia tsutsugamushi) [138]. 
All the members of the Ehrlichia, Neorickettsia and 
Wolbachia have been transferred to the Anaplasmata-
ceae family. The reorganization of the genera within the 
family Anaplasmataceae was based on the comparison 
of sequences from rrs and groESL operon and on the 
complete sequencing of several species of the family. 
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Genetic analyses in this family, in fact, have identified 
four distinct clusters:
• Anaplasma;
• Ehrlichia;
• Neorickettsia;
• Wolbachia [139] (Fig. 1).
The Anaplasma genus of the Anaplasmataceae fam-
ily now includes several species. Three species infect 
erytrocytes: Anaplasma marginale (A. marginale), 
responsible of a severe febrile haemolytic anemia in 
cattle. Dermacentor andersoni and Boophilus micro-
plus are the vectors. Anaplasma centrale (A. centrale) 
produces the same disease, usually mild in cattle, 
Anaplasma ovis a pathogen of sheep and goats. Two 
species infect WBC: Anaplasma bovis. the agent of 
bovine anaplasmosis, transmitted by Rhipicephalus 
appendiculatus and Amblyomma variegatum, infects 
monocytes, and A. phagocytophilum (ex.: E. equi, 
HGA) has as targets granulocytic cells. Anaplasma 
platys the agent of cyclic thrombocytopenia in dogs, 
transmitted by R. sanguineus, infects platelets. Some 
genetic differences between A. marginale and A. 
centrale, that tend to cluster together and A. phago-
cytophilum, have suggested that these species may be 
a distinct genus. It was, in fact, proposed to separate 
A. phagocytophilum from the group and, eventually, 
return it to the genus Cytoecetes as Cytoecetes phago-
cytophila. 
The Ehrlichia genus includes several human patho-
gens [140]: E. canis, E. chaffeensis, parasite circulating 
monocytes of humans and animals; E. ewingii infects 
granulocytes of dogs and man. Ehrlichia ruminan-
tium (E. ruminantium), formerly Cowdria ruminantium, 
transferred to the genus Ehrlichia [141], where it forms 
a distinct clade, is the agent of a severe disease of ru-
minants, the heartwater, infects endothelial cells and, 
beside the heart (hydropericardium: heartwater), may 
causes encephalitis. DNA of E. ruminantium has been 
detected in young patients [142]. Ehrlichia muris (E. 
muris), which also forms a distinct clade in the genus, is 
transmitted by the tick Haemaphysalis flava and infects 
rodents. E. muris has not been identified, yet, as agent 
of human disease.
Perpetuation of the genus Neorickettsia, formerly Ehr-
lichia spp, depends on trematodes and not on ticks. 
Neorickettsia helmintoeca infects the salmonid fluke 
Nanophyetus salmincola and causes a febrile illness in 
bears and dogs. The Potomac horse fever, a febrile ill-
ness with intestinal troubles and diarrhoea in horses that 
have ingested aquatic insects contaminated with meta-
cercaria, is caused by Neorickettsia risticii. Japanese 
and Malaysian residents that eat uncooked fish possibly 
contaminated by some kind of flukes infected with Ne-
orickettsia sennetsu may develop a mononucleosis-like 
disease. The fluke Stellantchasmus falcatus hosts the SF 
agent, a Neorickettsia which has not been reported in 
mammalian infective events.
Wolbachia are intracellular bacteria found in arthropods 
and in filarial nematodes [143, 144]. Wolbachia persica, 
formerly included in the genus, has been reclassified as 
Francisella persica. Wolbachia melophagi has an unde-
termined taxonomic position and seems more like the 
gammaproteobacteria [145].
Wolbachia pipientis, the sole species of the genus, has 
a complex molecular diversity and, by polyphasic gene 
analysis, six main different groups have been identified, 
named, at the moment, super-groups A-F [146]. Genetic 
divergences among the different groups may suggest 
that each group may be a single species with different 
variants. The single name, however, is maintained until 
new data may better clarified taxonomy and phylo-
geny [147].
The family Bartonellaceae are important zoonotic 
pathogens. The number of known Bartonella spp is ra-
pidly increasing; intermediate hosts are much more, in 
quantity and diversity, than previously thought, vectors 
are as well numerous and most of them not fully defi-
ned [148]. Various domestic and wild animals can serve 
as chronically infected reservoir hosts for various B. 
spp. Transmission is due to cat fleas but other vectors, 
ticks and biting flies, have been identified. Rochalimea 
has been included in the Bartonellaceae family. Cats 
can be infected with Bartonella henselae (B. henselae), 
Bartonella clarridgeiae (B. clarridgeiae), Bartonella 
bovis, Bartonella koehlerae (B. koehlerae), Bartonella 
quintana (B. quintana). Cats are an important reservoir 
and as many other species which act as reservoirs usual-
ly display chronic bacteriemia. Dogs can be infected by 
Bartonella vinsonii (B. vinsonii), B. henselae, B. clarri-
dgeiae, Bartonella washoensis, Bartonella elizabethae 
(B. elizabethae), B. quintana. Dogs develop a disease 
spectrum similar to humans and may be sentinels for 
infections in humans and a good research model. 7 of 
19 Bartonella species are potential pathogens for hu-
mans. B. quintana and B. henselae agents, respectively, 
of the trench fever and CSD, may also cause endocar-
ditis and bacillary angiomatosis in immunodepressed 
patients. Bartonella bacilliformis is the agent of Car-
rion’s disease. B. elizabethae and B. vinsonii berkhoffii 
Fig. 1. Order Rickettsiales, Family Anaplasmataceae.
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cause endocarditis, Bartonella grahamii (B. grahamii) 
neuroretinitis, B. vinsonii arupensis may affects the 
heart valves [149, 150]. Genetic analysis identified, at 
the moment, six evolutionary clusters. B. henselae, B. 
koelherae and B. quintana cluster togheter, as well as B. 
vinsonii vinsonii and B. vinsoni berkhoffii.
Bartonella bacilliformis and B. clarridgeiae seem to be di-
vergent species. A cluster includes Bartonella tribocorum, 
B. elizabethae, B. grahamii and a group of strains associa-
ted with rodents indigenous of the Old World and an other 
one includes bacteria isolated from various rodents belon-
ging to native species of the New World [151, 152].
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